News
Contact Us
Support

Home
Our Philosophy
OVITEX
Investors
Careers

Press Releases
Events & Presentations

News Releases

News Releases

Year

Nov 21, 2022

TELA Bio to Participate in Piper Sandler 34th Annual Healthcare Conference

Nov 09, 2022

TELA Bio Reports Third Quarter 2022 Financial Results

Nov 03, 2022

TELA Bio to Participate in Canaccord MedTech, Diagnostics and Digital Health & Services Forum

Oct 28, 2022

TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Oct 27, 2022

TELA Bio to Announce Third Quarter 2022 Financial Results

Oct 26, 2022

TELA Bio Announces Publication of 24-Month BRAVO Study Results Demonstrating Benefits of OviTex® Reinforced Tissue Matrix in Hernia Repair

Sep 01, 2022

TELA Bio to Participate in Upcoming Investor Conferences

Aug 23, 2022

TELA Bio to Participate in Inaugural Gilmartin Group Emerging Growth Company Showcase

Aug 18, 2022

TELA Bio Announces Closing of Public Offering of Common Stock and Full Exercise of Underwriter’s Option to Purchase Additional Shares

Aug 15, 2022

TELA Bio Announces Pricing of Public Offering of Common Stock

Pagination

Current page 1
Page 2
Page 3
Page 4
Next page
Last page

Print Page

RSS Feeds

Email Alerts

Contact IR

Privacy Policy
Legal
Contact Us

Linkedin
Facebook
Twitter
Instagram

©2022 TELA Bio, Inc. All Rights reserved.